With the acquisition, which closed Feb. 1, Avant joins Real Chemistry’s medical group, which swells to 450 staff across medcomms, med ed and medical affairs.
Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars
The Inhibrx pickup gives Sanofi access to INBRX-101, a human recombinant protein that is being investigated in patients with a rare disease known as alpha-1 antitrypsin deficiency.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix